| CTRI Number |
CTRI/2026/02/104781 [Registered on: 25/02/2026] Trial Registered Prospectively |
| Last Modified On: |
24/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Ayurvedic Drug Trial On Chronic Wounds |
|
Scientific Title of Study
|
Clinical Evaluation Of The Advanced Dressing Material Impregnated With Kshara Of Butea Monosperma And Taila Of Cynodon Dactylon In The Management Of Dushtavrana (Chronic Wound) - A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ankit Sarraf |
| Designation |
Junior Resident |
| Affiliation |
IMS , BHU |
| Address |
Department Of Shalya Tantra, Faculty of Ayurveda,IMS,BHU
Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
8871502227 |
| Fax |
|
| Email |
ankitsarraf36@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Rashmi Gupta |
| Designation |
Associate Professor |
| Affiliation |
IMS, BHU |
| Address |
Department Of Shalya Tantra, Faculty of Ayurveda,IMS,BHU
Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9532852272 |
| Fax |
|
| Email |
rashmi.gupta@bhu.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Rashmi Gupta |
| Designation |
Associate Professor |
| Affiliation |
IMS, BHU |
| Address |
Department Of Shalya Tantra, Faculty of Ayurveda,IMS,BHU
Varanasi
Varanasi UTTAR PRADESH 221005 India |
| Phone |
9532852272 |
| Fax |
|
| Email |
rashmi.gupta@bhu.ac.in |
|
|
Source of Monetary or Material Support
|
| Sir Sunderlal Hospital, Faculty of Ayurveda, IMS, BHU, Varanasi (U.P.) 221005 INDIA |
|
|
Primary Sponsor
|
| Name |
Department of Shalya Tantra Institute of Medical Sciences |
| Address |
Faculty of Ayurveda,Institute of medical sciences,Banaras Hindu University
Varanasi 221005
India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Ankit Sarraf |
Sir Sunderlal Hospital, Banaras Hindu University |
Opd No. 12,14,16A & NRC, Indian Medicine Wing
Department Of Shalya Tantra, Faculty of Ayurveda,IMS,BHU Varanasi UTTAR PRADESH |
8871502227
ankitsarraf36@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee IMS BHU |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:L984||Non-pressure chronic ulcer of skin, not elsewhere classified. Ayurveda Condition: DUSHTAVRANAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | bandhanakarma, बन्धनकर्म | (Procedure Reference: , Procedure details: After cleaning of wound with normal saline, Advanced dressing material impregnated with kshara of butea monosperma & taila of cynodon dactylon will be applied on wound area/ once daily for 28 days or till the complete healing of wound (whichever is earlier))
| | 2 | Comparator Arm (Non Ayurveda) | | - | Betadine | After cleaning of wound with normal saline, chemical/surgical wound debridement will be performed as required based on the clinical condition of the wound, gauze soaked with betadine will be applied on wound area / once daily for 28 days or till the complete healing of wound (whuchever is earlier) |
|
|
|
Inclusion Criteria
|
| Age From |
16.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Mild and moderately infected wounds of all types
2. Patients with controlled diabetes.
3. Wounds having duration of more than 3 weeks |
|
| ExclusionCriteria |
| Details |
1. Malignant ulcers
2. Tubercular ulcers
3. Syphilitic ulcers
4. Leprotic ulcers and other specific ulcers
5. Wounds with associated osteomyelitis
6. Anaemia (Hb<8g/dl)
7. Jaundice
8. Malnutrition
9. Wounds in HIV positive and immunocompromised patients
10. Severe infection
11. Uncontrolled diabetes |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Assessment of the wound healing activity of Advanced dressing material impregnated with Kshara of Butea Monosperma and Taila of Cynodon Dactylon
2. Assessment of wound healing rate |
28 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Comparison of wound healing activity of trial drug and control drug |
28 days |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
30/04/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="8" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This randomized controlled clinical trial on dushtavrana (chronic wound) is with objectives of to assess the wound healing activity of Advanced dressing material impregnated with kshara of butea monosperma and taila of cynodon dactylon , to assess the wound healing rate in 28 days and to compare wound healing activity of trial drug and control drug. |